HJ Science-B (06132.HK) Launches Global Offering at HK$81.80 per Share, Expected to List June 23
Newtimespace (newtimespace.com) reports that HJ Science Co., Ltd. (6132.HK) announced that the global offering comprises 13,600,000 H shares (subject to the over-allotment option), including 1,360,000 H shares under the Hong Kong public offering (subject to reallocation) and 12,240,000 H shares under the international placing (subject to reallocation and the over-allotment option). The offer price is HK$81.80 per offer share, plus 1.0% brokerage commission, 0.0027% SFC transaction levy, 0.00565% Stock Exchange trading fee, and 0.00015% AFRC transaction levy (payable in full in Hong Kong dollars upon application, with surplus refundable). The H shares will be traded in board lots of 100 H shares each, and the stock code will be 6132.
The global offering consists of a Hong Kong public offering of 1,360,000 shares initially, representing approximately 10% of the total offer shares, and an international placing of 12,240,000 shares, representing approximately 90%. Pursuant to the Listing Rules and the New Listing Applicant Guide, the maximum number of shares that may be reallocated to the Hong Kong public offering is 2,040,000 H shares, or 15% of the total initial offer shares.
The Company expects to grant an over-allotment option to international underwriters, exercisable by the sole overall coordinator from the listing date until 30 days after the deadline for Hong Kong public offering applications (i.e., July 17, 2026), to issue up to 2,040,000 additional H shares to cover any over-allocation.
The Hong Kong public offering commences at 9:00 a.m. on Friday, June 12, 2026. The deadline for White Form eIPO applications is 11:30 a.m. on Wednesday, June 17, 2026. The deadline for electronic application instructions to HKSCC is 12:00 noon on June 17, 2026. Dealings in the H shares on the Stock Exchange are expected to commence at 9:00 a.m. on Tuesday, June 23, 2026.
NewTimeSpace Disclaimer: All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.
- Annto Supply Chain Technology Co., Ltd. Submits HKEX Listing Application, Leading China’s Production Logistics Solutions
- True Health Medical Passes HKEX Listing Hearing; Core Percutaneous Surgical Robot Obtains NMPA Registration
- TIGERMED(03347.HK) will spend CNY 175.37 million to repurchase 4.44 million shares on Jun 12, 2026